Item 1.01. Entry into a Material Definitive Agreement.

On March 30, 2021, Inari Medical, Inc., a Delaware corporation (the "Company"), and Inari Medical International, Inc., a Delaware corporation and wholly owned subsidiary of the Company ("Inari Medical International"), entered into an amendment (the "Amendment") to the Loan, Guaranty and Security Agreement, dated as of September 4, 2020 (the "Credit Agreement" and, as amended by the Amendment, the "Amended Credit Agreement"), by and among the Company, as borrower, Inari Medical International, as guarantor, the lenders party thereto, and Bank of America, N.A., as agent for such lenders.

The Amendment, among other things, reduces the LIBOR "floor" component of the interest rate under the Credit Agreement from 1.0% per annum to 0.0% per annum. In addition, the Amendment provides for the application of specified LIBOR successor rates under certain circumstances, including in the event that LIBOR is determined to be unavailable.

The foregoing summary of the Amendment is qualified in its entirety by reference to the actual text of the Amendment, a copy of which is filed herewith as Exhibit 10.1.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth in Item 1.01 is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits



Exhibit
  No.       Description
  10.1        First Amendment to the Loan, Guaranty and Security Agreement, dated
            as of March 30, 2021

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses